NEW YORK, March 2 (GenomeWeb News) - Motif BioSciences announced today it has completed a $1.9-million financing round.
$500,000 of the financing was from lead investor Amphion and was announced in January. The completed financing was oversubscribed, Motif said in a statement.
The funding will support Motif's sample collection and analysis of two sets of genetic data from the Persian Gulf.
Motif BioSciences is a population genetics company using genetic data from the Persian Gulf region. It is headquartered in the US and UK and is 47-percent owned by Amphion.